The purpose of this clinical research study is to evaluate the effectiveness of a new medication to prevent migraine headaches. If you participate in this clinical trial, you will be closely monitored and evaluated regularly by our clinical and medical staff at each study visit. The Northwest Clinical Research Center has been conducting clinical trials since 1995 and quality patient care remains our first priority. Call our office today to get more information on how you can get involved.
FREQUENTLY ASKED QUESTIONS ABOUT CLINICAL TRIALS
Why do clinical trials exist?
The United States Food and Drug Administration (FDA) requires that all prescription medications be evaluated for safety and efficacy before they are marketed to the public. So before a new medication can be made available, it must undergo extensive testing. Clinical trials are part of this testing process.
Why do people participate in clinical trials?
People participate in migraine headache clinical trials for various reasons. Often they have tried the treatments that are currently available for migraines and have found that it did not work for them, so they would like to try something new.
Sometimes patients participate to help further medical research. They understand how important it is that new medications are available for migraines, and want to do their part to help.
Other times, a patient may not be able to afford the most current treatment available for their migraine headaches, and clinical trial participation offers a research medication at no cost.
Who can participate in a clinical trial?
All clinical trials have guidelines about who can participate; using inclusion/exclusion criteria is an important principle of medical research that helps to produce reliable results. The factors that allow someone to participate in a clinical trial are called “inclusion criteria” and those that disallow someone from participating are called “exclusion criteria”. These criteria are based on such factors as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. Before joining a clinical trial, a participant must qualify for the study. Some research studies seek participants with illnesses or conditions to be studied in the clinical trial, while others need healthy participants. It is important to note that inclusion and exclusion criteria are not used to reject people personally. Instead, the criteria are used to identify appropriate participants and keep them safe. The criteria help ensure that researchers will be able to answer the questions they plan to study.
What is informed consent?
Informed consent is the process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. Then the research team provides an informed consent document that includes details about the study, such as its purpose, duration, required procedures, and key contacts. Risks and potential benefits are explained in the informed consent document. The participant then decides whether or not to sign the document. Informed consent is not a contract, and the participant may withdraw from the trial at any time.
How can I get involved?
Northwest Clinical Research Center has been conducting Clinical Trials since 1995. We are committed to patient care and safety. If you wish to participate in a Treatment Resistant Depression clinical trial, you may contact Northwest Clinical Research Center by completing the form, or by using the contact information listed. One of our friendly staff will ask you some questions over the phone and schedule you for a screening visit to see if you qualify for one of our studies.
Does it cost anything to participate in the study?
There is no monetary cost to you to participate in this study, nor do you have to pay for the study drug, visits, or procedures that are a part of the clinical trial.